FIECON is a health economics consultancy born out of the desire to make a difference in the world we live in. Our founders realised that the best way to make a difference was by putting their expertise to best use – harnessing the power of health economics to bring life-changing products to market.
Kuntal Fisher and Mark Fisher established FIECON [FI(SHER) ECON(OMICS] in 2015, following a decade of experience in pharmaceutical companies and healthcare consultancies. Since its inception, FIECON has expanded from the two founders to a team of over 100 professionals, growing our ability to deliver high-quality solutions to our global clients.
In April 2025, FIECON joined forces with Herspiegel, a world leader in pharmaceutical and biotech commercialization services in the US. FIECON is now a Herspiegel company.
We are trusted partners to our pharma, med tech, and biotech clients. By respecting the technical and delivering the practical, FIECON provides commercial strategy alongside technical ability (not one or the other). We work creatively to generate ideas that solve our client's problems, but we know it’s about results, so we don’t stop until we know the solutions are implemented and working.
Great relationships come from collaboration; we're here to support the commercialisation of life-changing products for our pharma, med tech, and biotech clients and make a difference in the world.
